Author
Memorial Sloan Kettering Cancer CenterORCID 0000-0003-2054-4112Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Kyle B. Lupo, M. Kazim Panjwani, Aya G. Halawi…·Katharine C. Hsu
This study shows that engineered NKG2C+ NK-like T cells have better antitumor effects and lower cytokine release syndrome risk than conventional CAR-T and CAR-NK cells.
Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur…·Charles Kyriakos Vorkas
The paper identifies CD8+ NK cells as a Mtb-responsive population with enhanced maturity and cytotoxicity in human TB infection, correlating with disease resistance.
M. Kazim Panjwani, Simon A. Grassmann, Rosa Sottile…·Katharine C. Hsu
The paper identifies a naive-memory relationship between CD56bright and adaptive human natural killer cells through phenotypic, transcriptional, and functional profiling.